日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

2017年班夫肾脏病会议报告:慢性活动性T细胞介导排斥反应、抗体介导排斥反应的修订诊断标准,以及下一代临床试验综合终点的展望

Haas, M; Loupy, A; Lefaucheur, C; Roufosse, C; Glotz, D; Seron, D; Nankivell, B J; Halloran, P F; Colvin, R B; Akalin, Enver; Alachkar, N; Bagnasco, S; Bouatou, Y; Becker, J U; Cornell, L D; Duong van Huyen, J P; Gibson, I W; Kraus, Edward S; Mannon, R B; Naesens, M; Nickeleit, V; Nickerson, P; Segev, D L; Singh, H K; Stegall, M; Randhawa, P; Racusen, L; Solez, K; Mengel, M

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

2015年班夫肾脏病会议报告:排斥反应分类的当前挑战及分子病理学的应用前景

Loupy, A; Haas, M; Solez, K; Racusen, L; Glotz, D; Seron, D; Nankivell, B J; Colvin, R B; Afrouzian, M; Akalin, E; Alachkar, N; Bagnasco, S; Becker, J U; Cornell, L; Drachenberg, C; Dragun, D; de Kort, H; Gibson, I W; Kraus, E S; Lefaucheur, C; Legendre, C; Liapis, H; Muthukumar, T; Nickeleit, V; Orandi, B; Park, W; Rabant, M; Randhawa, P; Reed, E F; Roufosse, C; Seshan, S V; Sis, B; Singh, H K; Schinstock, C; Tambur, A; Zeevi, A; Mengel, M

Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study

干扰素γ ELISPOT检测作为肾移植损伤风险分层生物标志物:来自CTOT-01多中心研究的结果

Hricik, D E; Augustine, J; Nickerson, P; Formica, R N; Poggio, E D; Rush, D; Newell, K A; Goebel, J; Gibson, I W; Fairchild, R L; Spain, K; Iklé, D; Bridges, N D; Heeger, P S

Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.

多中心验证尿液 CXCL9 作为肾移植损伤风险分层生物标志物

Hricik D E, Nickerson P, Formica R N, Poggio E D, Rush D, Newell K A, Goebel J, Gibson I W, Fairchild R L, Riggs M, Spain K, Ikle D, Bridges N D, Heeger P S